查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1846137

全球狂犬病診斷市場規模（依診斷方法、技術、地區和預測）

Global Rabies Diagnostics Market Size By Diagnostic Method, By Technology, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

狂犬病診斷藥物市場規模及預測

預計狂犬病診斷市場在 2024 年的價值將達到 19 億美元，到 2031 年將達到 38 億美元，2024 年至 2031 年的複合年成長率為 4.9%。

推動全球狂犬病診斷市場的因素

狂犬病診斷市場的促進因素可能受到多種因素的影響。這些因素包括：

狂犬病發病率上升：越來越需要狂犬病診斷來識別患有狂犬病的動物並防止其傳播給人類，特別是在疫苗接種計劃不普遍的地區。

政府法規和措施：野生動物和寵物強制狂犬病疫苗接種計畫是政府主導的狂犬病控制措施的例子，這些措施可能會增加對狂犬病診斷產品的需求。動物進出口監管法律也可能影響市場環境。

技術進步：分子診斷（PCR）、次世代定序和快速免疫診斷測試等診斷技術的進步使得狂犬病診斷更加準確、快速和方便，從而擴大了市場。

寵物數量的增加：隨著全球寵物擁有量的增加，對狗、貓和其他家養動物進行狂犬病檢測的需求也隨之增加。

有關狂犬病感染風險和早期診斷價值的公眾意識提升宣傳活動和教育措施可以成為狂犬病診斷需求的主要驅動力。

全球旅行與旅遊：由於狂犬病跨境傳播的風險增加，遊客湧入較多的地區需要強大的診斷基礎設施。

動物福利問題：人們對動物福利和對待動物的道德意識的提高增加了對準確和富有同情心的狂犬病檢測技術的需求，並鼓勵使用尖端診斷技術。

疫情防治：為了快速發現和控制狂犬病疫情，特別是在疫情易發地區，政府和醫療機構將投資狂犬病診斷作為其防治計畫的一部分。

研究與發展：旨在提供狂犬病創新診斷、疫苗接種和治療方法的持續研究與開發創造了新的機會並刺激了創新，為診斷行業的擴張做出了貢獻。

夥伴關係與協作：政府機構、研究中心和診斷公司之間的聯盟和協作匯集資源和專業知識，以加速新診斷設備的開發和商業化，有助於擴大市場。

限制全球狂犬病診斷市場的因素

狂犬病診斷市場可能面臨多種限制和挑戰，包括：

監管障礙：診斷檢測的嚴格監管和冗長的核准程序可能會阻礙市場擴張。對於推出新診斷產品的公司來說，合規性可能是一個重大障礙。

基礎設施和意識有限：狂犬病流行的地區可能缺乏醫療保健基礎設施來提供廣泛的檢測或了解診斷的重要性。

成本高：診斷測試可能很昂貴，特別是在資源有限的環境中，這可能使診斷難以獲得，特別是在患病率高的地區。

技術限制：目前的診斷技術在靈敏度、特異性和檢測速度方面有其限制。為了克服這些局限性，需要創新診斷方法。

狂犬病的地理分佈：由於狂犬病在世界某些地區發病率較高，因此在發病率較低的地區，診斷產品的市場機會可能較少。

與替代方法的競爭：在資源匱乏且更傾向於經濟解決方案的環境中，狂犬病診斷的替代方案（例如臨床觀察或透過病毒分離進行實驗室確認）可能會與診斷測試競爭。

物流挑戰：將檢體從偏遠地區運送到診斷實驗室、管理低溫運輸以及按時完成測試和報告都具有物流挑戰性，尤其是在服務不足和農村地區。

抵制變革：由於程序過時或缺乏現代技術經驗，醫療保健系統和從業人員可能不願意採用新的診斷工具和程序。

經濟因素：預算限制和經濟衰退可能會減少醫療支出，影響診斷檢測的採用和整體市場擴張。狂犬病的感染疾病性意味著它可以傳播給人類和動物。由於環境條件、人類健康和動物健康之間的通用相互作用，狂犬病的診斷和治療可能帶來特殊的挑戰，需要多學科方法。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查方法

第2章執行摘要

  • 主要發現
  • 市場概況
  • 市場亮點

第3章 市場概況

  • 市場規模和成長潛力
  • 市場趨勢
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析

第4章 狂犬病診斷市場（依診斷方法）

  • 螢光抗體檢測（FAT）
  • 免疫組織化學（IHC）
  • 擴增方法
  • 組織學檢查
  • 血清學檢測

5. 狂犬病診斷市場（依技術）

  • ELISA/免疫組織化學（ELISA/IHC）
  • 層析法技術
  • PCR（聚合酵素鏈鎖反應）

第6章 區域分析

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第7章市場動態

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • COVID-19 市場影響

第8章 競爭態勢

  • 主要企業
  • 市佔率分析

第9章：公司簡介

  • Bio-Rad Laboratories, Inc.
  • Aviva Systems Biology Corporation
  • Norgen Biotek Corp.
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Abbexa Ltd.
  • MyBioSource.com
  • Express Biotech International Inc.
  • BioNote, Inc.

第10章：市場展望與機遇

  • 新興技術
  • 未來市場趨勢
  • 投資機會

第11章 市場展望 附錄

  • 簡稱列表
  • 來源和參考文獻
簡介目錄
Product Code: 31858

Rabies Diagnostics Market Size And Forecast

Rabies Diagnostics Market size was valued at USD 1.9 Billion in 2024 and is projected to reach USD 3.8 Billion by 2031, growing at a CAGR of 4.9% from 2024 to 2031.

Global Rabies Diagnostics Market Drivers

The market drivers for the Rabies Diagnostics Market can be influenced by various factors. These may include:

Rising Rabies Incidence: In order to identify diseased animals and stop human transmission, rabies diagnostics are becoming more and more necessary, especially in areas where vaccination programmes are less common.

Government Regulations And Initiatives: Mandatory rabies vaccination programmes for wildlife and pets are examples of government-led rabies control measures that may increase demand for rabies diagnostics. Market conditions may also be impacted by laws governing the import and export of animals.

Technological Advancements: The accuracy, speed, and convenience of diagnosing rabies are improved by advances in diagnostic technologies, including as molecular diagnostics (PCR), next-generation sequencing, and quick immunodiagnostic testing. This expands the market.

Growing Pet Ownership: As the number of people owning pets rises around the world, there is a greater need for rabies diagnostics for dogs, cats, and other household animals.

Public awareness campaigns and education initiatives regarding the dangers of rabies transmission and the value of early diagnosis can be the main drivers of the need for rabies diagnostics.

Worldwide Travel And Tourism: As a result of the increased danger of rabies transmission across countries, areas with significant tourist influxes must have a strong diagnostic infrastructure.

Animal Welfare Concerns: As awareness of animal welfare and the morality of treating animals grows, so does the need for precise and compassionate rabies testing techniques, which encourages the use of cutting-edge diagnostic technologies.

Outbreak Preparedness: To swiftly detect and contain outbreaks, especially in areas vulnerable to epidemics, governments and healthcare institutions invest in rabies diagnostics as part of their preparedness plans.

Research And Development: By generating new opportunities and spurring innovation, ongoing research and development efforts targeted at providing innovative diagnostic methods, vaccinations, and therapies for rabies help to expand the diagnostics industry.

Partnerships And Collaborations: By pooling resources and expertise, partnerships and collaborations between government agencies, research centres, and diagnostic companies help to create and commercialise new diagnostic instruments and propel market expansion.

Global Rabies Diagnostics Market Restraints

Several factors can act as restraints or challenges for the Rabies Diagnostics Market. These may include:

Regulatory Obstacles: Tight rules and lengthy approval procedures for diagnostic testing may impede the expansion of the market. For businesses launching new diagnostics, regulatory compliance may pose a serious obstacle.

Limited Infrastructure And Awareness: In areas where rabies is endemic, there may be insufficient healthcare infrastructure to provide widespread testing or a lack of knowledge of the significance of diagnostics.

High Costs: The price of diagnostic testing can be unaffordable, particularly in environments with limited resources. This may make diagnostics more difficult to get, especially in places where prevalence rates are high.

Technological Restrictions: The sensitivity, specificity, or speed of detection of current diagnostic techniques may be limited. To overcome these constraints, technological innovations in diagnostics are required.

Geographic Distribution Of Rabies: Because rabies is more common in some areas of the world, there may be less market opportunity for diagnostics in places with lower incidence rates.

Competition From Alternative Methods: In resource-constrained environments where economical solutions are favoured, alternative methods for diagnosing rabies, such as clinical observation or laboratory confirmation through virus isolation, may compete with diagnostic testing.

Logistical Difficulties: Sample transportation from remote locations to diagnostic labs, cold chain management, and making sure testing and reporting are completed on time can all be logistically difficult, particularly in underserved or rural areas.

Opposition To Change: Because of long-standing procedures or a lack of experience with more recent techniques, healthcare systems and practitioners may be reluctant to embrace new diagnostic tools or procedures.

Economic Factors: Financial strains or downturns may result in lower expenditure on healthcare, which may have an impact on the uptake of diagnostic tests and the expansion of the market as a whole. The zoonotic nature of rabies refers to the fact that the disease can infect both humans and animals. The intricate relationship among environmental conditions, human health, and animal health might create special difficulties for diagnosing and treating rabies, necessitating a multidisciplinary approach.

Global Rabies Diagnostics Market Segmentation Analysis

The Global Rabies Diagnostics Market is Segmented on the basis of Diagnostic Method, Technology, And Geography.

Rabies Diagnostics Market, By Diagnostic Method

Fluorescent Antibody Test (FAT): This is the gold standard for rabies diagnosis, but it requires specialized equipment and trained personnel.

Immunohistochemical Test (IHC): Similar to FAT, IHC is a confirmatory test that can identify rabies virus antigens in tissue samples.

Amplification Methods: These tests, like Polymerase Chain Reaction (PCR), can detect the rabies virus's genetic material, offering high sensitivity and specificity.

Histologic Examination: This method involves examining brain tissue samples under a microscope for signs of rabies infection.

Serology Tests: These tests measure antibodies against the rabies virus in a person's blood, indicating past exposure or vaccination.

Rabies Diagnostics Market, By Technology

ELISA/Immunohistochemistry (ELISA/IHC): These are common techniques used in various diagnostic tests, including rabies. ELISA involves an antigen-antibody reaction, while IHC uses antibodies to locate specific antigens in tissue samples.

Chromatography Techniques: These techniques separate components of a mixture, which can be helpful in rabies diagnosis for isolating the virus.

PCR (Polymerase Chain Reaction): A powerful technique for amplifying specific DNA sequences, allowing for highly sensitive detection of the rabies virus.

Rabies Diagnostics Market, By Geography

North America: Market conditions and demand in the United States, Canada, and Mexico.

Europe: Analysis of the Rabies Diagnostics Market in European countries.

Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.

Middle East and Africa: Examining market dynamics in the Middle East and African regions.

Latin America: Covering market trends and developments in countries across Latin America.

Key Players

  • The major players in the Rabies Diagnostics Market are:
  • Bio-Rad Laboratories, Inc.
  • Aviva Systems Biology Corporation
  • Norgen Biotek Corp.
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Abbexa Ltd.
  • MyBioSource.com
  • Express Biotech International Inc.
  • BioNote, Inc.
  • Merck KGaA

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Rabies Diagnostics Market, By Diagnostic Method

  • Fluorescent Antibody Test (FAT)
  • Immunohistochemical Test (IHC)
  • Amplification Methods
  • Histologic Examination
  • Serology Tests

5. Rabies Diagnostics Market, By Technology

  • ELISA/Immunohistochemistry (ELISA/IHC)
  • Chromatography Techniques
  • PCR (Polymerase Chain Reaction)

6. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

7. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

8. Competitive Landscape

  • Key Players
  • Market Share Analysis

9. Company Profiles

  • Bio-Rad Laboratories, Inc.
  • Aviva Systems Biology Corporation
  • Norgen Biotek Corp.
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Abbexa Ltd.
  • MyBioSource.com
  • Express Biotech International Inc.
  • BioNote, Inc.

10. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

11. Appendix

  • List of Abbreviations
  • Sources and References